Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

CDA 09-028 – HSR&D Study

New | Current | Completed | DRA | DRE | Portfolios/Projects | Centers | Career Development Projects

CDA 09-028
Attaining Optimal Non-HDL Cholesterol Levels to Improve Cardiac Outcomes
Salim Virani MD
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, TX
Funding Period: July 2010 - June 2015

BACKGROUND/RATIONALE:
Despite optimal revascularization and achieving optimal low-density-lipoprotein cholesterol (LDL-C) levels, patients with coronary heart disease (CHD) continue to have recurrent events. Recently, non-HDL-cholesterol (non-HDL-C) has shown to predict recurrent events in CHD patients and has been added as a secondary treatment goal by the Adult Treatment Panel (ATP) III cholesterol management guidelines. The current gaps include that it is unknown (a) what is the goal attainment for non-HDL-C in CHD patients (b) what are the system of care characteristics associated with attainment of non-HDL-C treatment goals (c) what system and patient-level interventions can improve non-HDL-C goal attainment.

OBJECTIVE(S):
Aim 1 of this Career Development Award is to identify facility, provider, and patient correlates of non-HDL-C goal attainment. We also aim to identify system and patient-level interventions that could impact non-HDL-C goal attainment (aim 2).

METHODS:
Methods for aim 1 included review of the VA administrative data and a questionnaire survey of providers to understand correlates and gaps in non-HDL-C goal attainment. Aim 2 will evaluate impact of strategies (system, provider, and patient level) that could improve non-HDL-C goal attainment.

FINDINGS/RESULTS:
Not yet available.

IMPACT:
Our research has identified facility, provider, and patient-level characteristics associated with dual LDL-C/non-HDL-C goal attainment as per ATP III cholesterol management guidelines. In addition, our recent research based on the 2013 ACC/AHA updated cholesterol management guidelines have identified gaps in cholesterol management in the VA system which could be targets for future intervention.

PUBLICATIONS:

Journal Articles

  1. Ogunwale AN, Morrison AC, Sun W, Dodge RC, Virani SS, Taylor A, Gottesman RF, Yang E, Wei P, McEvoy JW, Heiss G, Boerwinkle E, Ballantyne CM, Nambi V. The impact of multiple single day blood pressure readings on cardiovascular risk estimation: The Atherosclerosis Risk in Communities study. European journal of preventive cardiology. 2016 Sep 1; 23(14):1529-36.
  2. Hoang V, Alam M, Addison D, Macedo F, Virani S, Birnbaum Y. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials. Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy. 2016 Apr 1; 30(2):189-98.
  3. Pokharel Y, Wei J, Hira RS, Kalra A, Shore S, Kerkar PG, Kumar G, Risch S, Vicera V, Oetgen WJ, Deswal A, Turakhia MP, Glusenkamp N, Virani SS. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program. Clinical Cardiology. 2016 Mar 1; 39(3):145-9.
  4. Murray T, Yang EY, Brunner G, Kumar A, Lakkis N, Misra A, Virani SS, Hartley CJ, Morrisett JD, Ballantyne CM, Nambi V. Postprandial effects on arterial stiffness parameters in healthy young adults. Vascular medicine (London, England). 2015 Dec 1; 20(6):501-8.
  5. Virani SS, Akeroyd JM, Nambi V, Maddox TM, Gillette MA, Michael Ho P, Rumsfeld J, Petersen LA, Ballantyne CM. Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria. The American journal of medicine. 2015 Nov 1; 128(11):1253-6.
  6. Virani SS, Maddox TM, Chan PS, Tang F, Akeroyd JM, Risch SA, Oetgen WJ, Deswal A, Bozkurt B, Ballantyne CM, Petersen LA. Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry. Journal of the American College of Cardiology. 2015 Oct 20; 66(16):1803-12.
  7. Miedema MD, Lopez FL, Blaha MJ, Virani SS, Coresh J, Ballantyne CM, Folsom AR. Implications of the Eighth Joint National Committee Guidelines for the Management of High Blood Pressure for Aging Adults: Atherosclerosis Risk in Communities Study. Hypertension. 2015 Sep 1; 66(3):474-80.
  8. Miller PE, Martin SS, Toth PP, Santos RD, Blaha MJ, Nasir K, Virani SS, Post WS, Blumenthal RS, Jones SR. Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17). Journal of clinical lipidology. 2015 Sep 1; 9(5):676-83.
  9. Quispe R, Manalac RJ, Faridi KF, Blaha MJ, Toth PP, Kulkarni KR, Nasir K, Virani SS, Banach M, Blumenthal RS, Martin SS, Jones SR. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study. Atherosclerosis. 2015 Sep 1; 242(1):243-50.
  10. Spinler SA, Cziraky MJ, Willey VJ, Tang F, Maddox TM, Thomas T, Dueñas GG, Virani SS, NCDR. Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry). The American journal of cardiology. 2015 Aug 15; 116(4):547-53.
  11. O'Brien SE, Schrodi SJ, Ye Z, Brilliant MH, Virani SS, Brautbar A. Differential Lipid Response to Statins Is Associated With Variants in the BUD13-APOA5 Gene Region. Journal of cardiovascular pharmacology. 2015 Aug 1; 66(2):183-8.
  12. Kalra A, Pokharel Y, Hira RS, Risch S, Vicera V, Li Q, Kalra RN, Kerkar PG, Kumar G, Maddox TM, Oetgen WJ, Glusenkamp N, Turakhia MP, Virani SS. Cardiovascular Disease Performance Measures in the Outpatient Setting in India: Insights From the American College of Cardiology's PINNACLE India Quality Improvement Program (PIQIP). Journal of the American Heart Association. 2015 May 20; 4(5).
  13. Pokharel Y, Virani SS, Ballantyne CM. The promise of proprotein convertase subtilisin/kexin 9 inhibitors for the treatment of familial hypercholesterolemia. Current Atherosclerosis Reports. 2015 May 1; 17(5):508.
  14. Bandeali SJ, Gosch K, Alam M, Kayani WT, Jneid H, Fiocchi F, Wilson JM, Chan PS, Deswal A, Maddox TM, Virani SS. Coronary artery disease performance measures and statin use in patients with recent percutaneous coronary intervention or recent coronary artery bypass grafting (from the NCDR PINNACLE registry). The American journal of cardiology. 2015 Apr 15; 115(8):1013-8.
  15. Winchester DE, Kitchen A, Brandt JC, Dusaj RS, Virani SS, Bradley SM, Shaw LJ, Beyth RJ. Metrics of quality care in veterans: correlation between primary-care performance measures and inappropriate myocardial perfusion imaging. Clinical Cardiology. 2015 Apr 13; 38(4):195-9.
  16. Abbass IM, Krause TM, Virani SS, Swint JM, Chan W, Franzini L. Revisiting the economic efficiencies of observation units. Managed Care (Langhorne, Pa.). 2015 Mar 1; 24(3):46-52.
  17. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015 Jan 27; 131(4):e29-322.
  18. Hira RS, Kennedy K, Nambi V, Jneid H, Alam M, Basra SS, Ho PM, Deswal A, Ballantyne CM, Petersen LA, Virani SS. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. Journal of the American College of Cardiology. 2015 Jan 20; 65(2):111-21.
  19. Khalid U, Awar O, Verstovsek G, Cheong B, Yellapragada SV, Jneid H, Deswal A, Virani SS. Case report: isolated cardiac amyloidosis: an enigma unravelled. Methodist DeBakey cardiovascular journal. 2015 Jan 1; 11(1):53-8.
  20. Miedema MD, Lopez FL, Blaha MJ, Virani SS, Coresh J, Ballantyne CM, Folsom AR. Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort. JAMA internal medicine. 2015 Jan 1; 175(1):138-40.
  21. Pokharel Y, Sun W, de Lemos JA, Taffet GE, Virani SS, Ndumele CE, Mosley TH, Hoogeveen RC, Coresh J, Wright JD, Heiss G, Boerwinkle EA, Bozkurt B, Solomon SD, Ballantyne CM, Nambi V. High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities study. Hypertension. 2015 Jan 1; 65(1):78-84.
  22. Virani SS, Woodard LD, Ramsey DJ, Urech TH, Akeroyd JM, Shah T, Deswal A, Bozkurt B, Ballantyne CM, Petersen LA. Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. The American journal of cardiology. 2015 Jan 1; 115(1):21-6.
  23. Khalid U, Ather S, Bavishi C, Chan W, Loehr LR, Wruck LM, Rosamond WD, Chang PP, Coresh J, Virani SS, Nambi V, Bozkurt B, Ballantyne CM, Deswal A. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. Journal of the American College of Cardiology. 2014 Dec 30; 64(25):2743-9.
  24. Basra SS, Pokharel Y, Hira RS, Bandeali SJ, Nambi V, Deswal A, Nasir K, Martin SS, Vogel RA, Roberts AJ, Ballantyne CM, Virani SS. Relation between playing position and coronary artery calcium scores in retired National Football League players. The American journal of cardiology. 2014 Dec 15; 114(12):1836-40.
  25. Wijeysundera DN, Duncan D, Nkonde-Price C, Virani SS, Washam JB, Fleischmann KE, Fleisher LA. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Journal of the American College of Cardiology. 2014 Dec 9; 64(22):2406-25.
  26. Wijeysundera DN, Duncan D, Nkonde-Price C, Virani SS, Washam JB, Fleischmann KE, Fleisher LA, ACC/AHA Task Force Members. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 9; 130(24):2246-64.
  27. Maddox TM, Borden WB, Tang F, Virani SS, Oetgen WJ, Mullen JB, Chan PS, Casale PN, Douglas PS, Masoudi FA, Farmer SA, Rumsfeld JS. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry. Journal of the American College of Cardiology. 2014 Dec 2; 64(21):2183-92.
  28. Virani SS, Woodard LD, Akeroyd JM, Ramsey DJ, Ballantyne CM, Petersen LA. Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines. Clinical Cardiology. 2014 Nov 1; 37(11):653-9.
  29. Abbass IM, Virani SS, Michael Swint J, Chan W, Franzini L. One-year outcomes associated with using observation services in triaging patients with nonspecific chest pain. Clinical Cardiology. 2014 Oct 1; 37(10):591-6.
  30. Pokharel Y, Basra S, Lincoln AE, Tucker AM, Nambi V, Nasir K, Vogel RA, Wong ND, Boone JL, Roberts AJ, Ballantyne CM, Virani SS. Association of body mass index and waist circumference with subclinical atherosclerosis in retired NFL players. Southern Medical Journal. 2014 Oct 1; 107(10):633-9.
  31. Pokharel Y, Nambi V, Martin SS, Hoogeveen RC, Nasir K, Khera A, Wong ND, Jones PH, Boone J, Roberts AJ, Ballantyne CM, Virani SS. Association between lipoprotein associated phospholipase A2 mass and subclinical coronary and carotid atherosclerosis in Retired National Football League players. Atherosclerosis. 2014 Oct 1; 236(2):251-6.
  32. Basra SS, Virani SS, Paniagua D, Kar B, Jneid H. Acute coronary syndromes: unstable angina and non-ST elevation myocardial infarction. Cardiology Clinics. 2014 Aug 1; 32(3):353-70.
  33. Pokharel Y, Macedo FY, Nambi V, Martin SS, Nasir K, Wong ND, Boone J, Roberts AJ, Ballantyne CM, Virani SS. Neck circumference is not associated with subclinical atherosclerosis in retired National Football League players. Clinical Cardiology. 2014 Jul 1; 37(7):402-7.
  34. Bavishi C, Ather S, Bambhroliya A, Jneid H, Virani SS, Bozkurt B, Deswal A. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. The American journal of cardiology. 2014 Jun 1; 113(11):1834-8.
  35. Gao F, Ballantyne C, Ma L, Virani SS, Keinan A, Brautbar A. Rare LPL gene variants attenuate triglyceride reduction and HDL cholesterol increase in response to fenofibric acid therapy in individuals with mixed dyslipidemia. Atherosclerosis. 2014 Jun 1; 234(2):249-53.
  36. Virani SS. What is new in the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic risk in adults? Texas Heart Institute journal. 2014 Jun 1; 41(3):304-5.
  37. Hoogeveen RC, Gaubatz JW, Sun W, Dodge RC, Crosby JR, Jiang J, Couper D, Virani SS, Kathiresan S, Boerwinkle E, Ballantyne CM. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arteriosclerosis, Thrombosis, and Vascular Biology. 2014 May 1; 34(5):1069-77.
  38. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21; 129(3):399-410.
  39. Martin SS, Blaha MJ, Blankstein R, Agatston A, Rivera JJ, Virani SS, Ouyang P, Jones SR, Blumenthal RS, Budoff MJ, Nasir K. Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis. Circulation. 2014 Jan 7; 129(1):77-86.
  40. Brunner G, Yang EY, Kumar A, Sun W, Virani SS, Negi SI, Murray T, Lin PH, Hoogeveen RC, Chen C, Dong JF, Kougias P, Taylor A, Lumsden AB, Nambi V, Ballantyne CM, Morrisett JD. The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT). Atherosclerosis. 2013 Dec 1; 231(2):371-7.
  41. Nambi V, Liu X, Chambless LE, de Lemos JA, Virani SS, Agarwal S, Boerwinkle E, Hoogeveen RC, Aguilar D, Astor BC, Srinivas PR, Deswal A, Mosley TH, Coresh J, Folsom AR, Heiss G, Ballantyne CM. Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study. Clinical Chemistry. 2013 Dec 1; 59(12):1802-10.
  42. Huang HD, Alam M, Hamzeh I, Virani S, Deswal A, Aguilar D, Rogers P, Kougias P, Birnbaum Y, Paniagua D, Kar B, Ballantyne C, Bozkurt B, Jneid H. Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. International Journal of Cardiology. 2013 Oct 9; 168(4):3741-6.
  43. Bandeali SJ, Kayani WT, Lee VV, Elayda M, Alam M, Huang HD, Wilson JM, Jneid H, Birnbaum Y, Deswal A, Farmer J, Ballantyne CM, Virani SS. Association between preoperative diuretic use and in-hospital outcomes after cardiac surgery. Cardiovascular therapeutics. 2013 Oct 1; 31(5):291-7.
  44. Alam M, Virani SS, Shahzad SA, Siddiqui S, Siddiqui KH, Mumtaz SA, Kleiman NS, Coselli JS, Lakkis NM, Jneid H. Comparison by meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with a mean age of =70 years. The American journal of cardiology. 2013 Sep 1; 112(5):615-22.
  45. Alam M, Huang HD, Shahzad SA, Kar B, Virani SS, Rogers PA, Paniagua D, Bozkurt B, Palacios I, Kleiman NS, Jneid H. Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients. Circulation journal : official journal of the Japanese Circulation Society. 2013 Aug 12; 77(2):372-82.
  46. Alam M, Bandeali SJ, Kayani WT, Ahmad W, Shahzad SA, Jneid H, Birnbaum Y, Kleiman NS, Coselli JS, Ballantyne CM, Lakkis N, Virani SS. Comparison by meta-analysis of mortality after isolated coronary artery bypass grafting in women versus men. The American journal of cardiology. 2013 Aug 1; 112(3):309-17.
  47. Yang EY, Brunner G, Dokainish H, Hartley CJ, Taffet G, Lakkis N, Taylor AA, Misra A, McCulloch ML, Morrisett JD, Virani SS, Ballantyne CM, Nagueh SF, Nambi V. Application of speckle-tracking in the evaluation of carotid artery function in subjects with hypertension and diabetes. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2013 Aug 1; 26(8):901-909.e1.
  48. Alam M, Lee VV, Elayda MA, Shahzad SA, Yang EY, Nambi V, Jneid H, Pan W, Coulter S, Wilson JM, Ramanathan KB, Ballantyne CM, Virani SS. Association of gender with morbidity and mortality after isolated coronary artery bypass grafting. A propensity score matched analysis. International Journal of Cardiology. 2013 Jul 15; 167(1):180-4.
  49. Virani SS. Implementation strategies to improve non-HDL-cholesterol goal attainment: current evidence and a conceptual framework for future directions. Texas Heart Institute journal. 2013 Jul 12; 39(2):228-30.
  50. Brautbar A, Barbalic M, Chen F, Belmont J, Virani SS, Scherer S, Hegele RA, Ballantyne CM. Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy. Journal of Lipid Research. 2013 Jul 1; 54(7):1980-7.
  51. Dadu RT, Fornage M, Virani SS, Nambi V, Hoogeveen RC, Boerwinkle E, Alonso A, Gottesman RF, Mosley TH, Ballantyne CM. Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study. Stroke. 2013 Jul 1; 44(7):1803-8.
  52. Jneid H, Alam M, Virani SS, Bozkurt B. Redefining myocardial infarction: what is new in the ESC/ACCF/AHA/WHF Third Universal Definition of myocardial infarction? Methodist DeBakey cardiovascular journal. 2013 Jul 1; 9(3):169-72.
  53. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 1; 127(1):e6-e245.
  54. Virani SS. Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths. Texas Heart Institute journal. 2013 Jan 1; 40(3):288-9.
  55. Alam M, Kayani WT, Bandeali SJ, Shahzad SA, Huang HD, Virani SS, Ramanathan KB, Jneid H. Impact of colchicine on pericardial inflammatory syndromes--an analysis of randomized clinical trials. International Journal of Cardiology. 2012 Nov 1; 161(1):59-62.
  56. Virani SS, Wang D, Woodard LD, Chitwood SS, Landrum CR, Zieve FJ, Ballantyne CM, Petersen LA. Non-high-density lipoprotein cholesterol reporting and goal attainment in primary care. Journal of clinical lipidology. 2012 Nov 1; 6(6):545-52.
  57. Bandeali SJ, Kayani WT, Lee VV, Pan W, Elayda MA, Nambi V, Jneid HM, Alam M, Wilson JM, Birnbaum Y, Ballantyne CM, Virani SS. Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting. The American journal of cardiology. 2012 Oct 1; 110(7):919-23.
  58. Woodard LD, Landrum CR, Urech TH, Wang D, Virani SS, Petersen LA. Impact of clinical complexity on the quality of diabetes care. The American journal of managed care. 2012 Sep 1; 18(9):508-14.
  59. Brautbar A, Pompeii LA, Dehghan A, Ngwa JS, Nambi V, Virani SS, Rivadeneira F, Uitterlinden AG, Hofman A, Witteman JC, Pencina MJ, Folsom AR, Cupples LA, Ballantyne CM, Boerwinkle E. A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. Atherosclerosis. 2012 Aug 1; 223(2):421-6.
  60. Virani SS, Brautbar A, Lee VV, MacArthur E, Morrison AC, Grove ML, Nambi V, Frazier L, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease. Circulation journal : official journal of the Japanese Circulation Society. 2012 Jun 25; 76(4):950-6.
  61. Dugan J, Virani SS, Ho V. Medicare eligibility and physician utilization among adults with coronary heart disease and stroke. Medical care. 2012 Jun 1; 50(6):547-53.
  62. Virani SS, Pompeii L, Lincoln AE, Dunn RE, Tucker AM, Nambi V, Nasir K, Vogel RA, Boone JL, Roberts AJ, Ballantyne CM. Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players. Atherosclerosis. 2012 Jun 1; 222(2):551-6.
  63. Alam M, Bandeali SJ, Virani SS, Jneid HM, Shahzad SA, Ramanathan KB, Kar B, Kleiman NS, Lakkis N. Clinical outcomes of percutaneous interventions in saphenous vein grafts using drug-eluting stents compared to bare-metal stents: a comprehensive meta-analysisof all randomized clinical trials. Clinical Cardiology. 2012 May 1; 35(5):291-6.
  64. Nambi V, Boerwinkle E, Lawson K, Brautbar A, Chambless L, Franeschini N, North KE, Virani SS, Folsom AR, Ballantyne CM. The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2012 May 1; 222(1):135-7.
  65. Kayani WT, Huang HD, Bandeali S, Virani SS, Wilson JM, Birnbaum Y. ST elevation: telling pathology from the benign patterns. Global journal of health science. 2012 Apr 28; 4(3):51-63.
  66. Brautbar A, Virani SS, Belmont J, Nambi V, Jones PH, Ballantyne CM. LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia. Journal of Lipid Research. 2012 Mar 1; 53(3):556-60.
  67. Tolpin DA, Collard CD, Lee VV, Virani SS, Allison PM, Elayda MA, Pan W. Subclinical changes in serum creatinine and mortality after coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery. 2012 Mar 1; 143(3):682-688.e1.
  68. Woodard LD, Landrum CR, Urech TH, Profit J, Virani SS, Petersen LA. Treating chronically ill people with diabetes mellitus with limited life expectancy: implications for performance measurement. Journal of the American Geriatrics Society. 2012 Feb 1; 60(2):193-201.
  69. Virani SS, Brautbar A, Davis BC, Nambi V, Hoogeveen RC, Sharrett AR, Coresh J, Mosley TH, Morrisett JD, Catellier DJ, Folsom AR, Boerwinkle E, Ballantyne CM. Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2012 Jan 17; 125(2):241-9.
  70. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 3; 125(1):e2-e220.
  71. Negi SI, Steinberg L, Polsani VR, Gowani SA, Nambi V, Kumar V, Marinescu V, Jones PH, Petersen LA, Ballantyne CM, Virani SS. Non-high-density lipoprotein cholesterol calculation and goal awareness among physicians-in-training. Journal of clinical lipidology. 2012 Jan 1; 6(1):50-7.
  72. Yang EY, Chambless L, Sharrett AR, Virani SS, Liu X, Tang Z, Boerwinkle E, Ballantyne CM, Nambi V. Carotid arterial wall characteristics are associated with incident ischemic stroke but not coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2012 Jan 1; 43(1):103-8.
  73. Brautbar A, Covarrubias D, Belmont J, Lara-Garduno F, Virani SS, Jones PH, Leal SM, Ballantyne CM. Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia. Atherosclerosis. 2011 Dec 1; 219(2):737-42.
  74. Virani SS, Ballantyne CM. Update on therapies targeting HDL: the mystery continues. Current Opinion in Lipidology. 2011 Dec 1; 22(6):514-6.
  75. Virani SS, Catellier DJ, Pompeii LA, Nambi V, Hoogeveen RC, Wasserman BA, Coresh J, Mosley TH, Otvos JD, Sharrett AR, Boerwinkle E, Ballantyne CM. Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. Atherosclerosis. 2011 Dec 1; 219(2):596-602.
  76. Yang EY, Dokainish H, Virani SS, Misra A, Pritchett AM, Lakkis N, Brunner G, Bobek J, McCulloch ML, Hartley CJ, Ballantyne CM, Nagueh SF, Nambi V. Segmental analysis of carotid arterial strain using speckle-tracking. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2011 Nov 1; 24(11):1276-1284.e5.
  77. Brunner G, Nambi V, Yang E, Kumar A, Virani SS, Kougias P, Shah D, Lumsden A, Ballantyne CM, Morrisett JD. Automatic quantification of muscle volumes in magnetic resonance imaging scans of the lower extremities. Magnetic resonance imaging. 2011 Oct 1; 29(8):1065-75.
  78. Virani SS, Woodard LD, Chitwood SS, Landrum CR, Urech TH, Wang D, Murawsky J, Ballantyne CM, Petersen LA. Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease. American heart journal. 2011 Oct 1; 162(4):725-732.e1.
  79. Virani SS, Steinberg L, Murray T, Negi S, Nambi V, Woodard LD, Bozkurt B, Petersen LA, Ballantyne CM. Barriers to non-HDL cholesterol goal attainment by providers. The American journal of medicine. 2011 Sep 1; 124(9):876-80.e2.
  80. Yang EY, Polsani VR, Washburn MJ, Zang W, Hall AL, Virani SS, Hodge MD, Parker D, Kerwin WS, Lawrie GM, Garami Z, Ballantyne CM, Morrisett JD, Nambi V. Real-time co-registration using novel ultrasound technology: ex vivo validation and in vivo applications. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2011 Jul 1; 24(7):720-8.
  81. Virani SS, Woodard LD, Landrum CR, Pietz K, Wang D, Ballantyne CM, Petersen LA. Institutional, provider, and patient correlates of low-density lipoprotein and non-high-density lipoprotein cholesterol goal attainment according to the Adult Treatment Panel III guidelines. American heart journal. 2011 Jun 1; 161(6):1140-6.
  82. Alam M, Siddiqui S, Lee VV, Elayda MA, Nambi V, Yang EY, Jneid HM, Wilson JM, Ballantyne CM, Virani SS. Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomes. Circulation journal : official journal of the Japanese Circulation Society. 2011 May 25; 75(6):1378-85.
  83. Virani SS, Brautbar A, Lee VV, Elayda M, Sami S, Nambi V, Frazier L, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Usefulness of single nucleotide polymorphism in chromosome 4q25 to predict in-hospital and long-term development of atrial fibrillation and survival in patients undergoing coronary artery bypass grafting. The American journal of cardiology. 2011 May 15; 107(10):1504-9.
  84. Virani S, Steinberg L, Murray T, Negi S, Nambi V, Woodard LD, Bozkurt B, Petersen LA, Ballantyne CM. Barriers to Non-HDL Cholesterol Goal Attainment by Providers. Journal of clinical lipidology. 2011 May 1; 5(3):211-213.
  85. Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, Hoogeveen RC, Liu X, Astor BC, Mosley TH, Folsom AR, Heiss G, Coresh J, Ballantyne CM. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation. 2011 Apr 5; 123(13):1367-76.
  86. Saunders J, Nambi V, Kimball KT, Virani SS, Morrisett JD, Lumsden AB, Ballantyne CM, Dong JF, ELIMIT Investigators. Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients. Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter. 2011 Mar 1; 53(3):668-75.
  87. Virani SS, Nambi V, Hoogeveen R, Wasserman BA, Coresh J, Gonzalez F, Chambless LE, Mosley TH, Boerwinkle E, Ballantyne CM. Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. European heart journal. 2011 Feb 1; 32(4):459-68.
  88. Virani SS. Non-HDL cholesterol as a metric of good quality of care: opportunities and challenges. Texas Heart Institute journal. 2011 Jan 1; 38(2):160-2.
Journal Other

  1. Brautbar A, Leary E, Rasmussen K, Wilson DP, Steiner RD, Virani S. Genetics of familial hypercholesterolemia. [Book Review]. Current Atherosclerosis Reports. 2015 Apr 1; 17(4):491.
  2. Habib GB, Virani SS, Jneid H. Is 2015 the primetime year for prehypertension? Prehypertension: a cardiovascular risk factor or simply a risk marker? Journal of the American Heart Association. 2015 Feb 19; 4(2).
  3. Hira RS, Kennedy K, Alam M, Petersen LA, Ballantyne CM, Virani SS. Reply: Frequency of inappropriate and nonrecommended prasugrel prescription: great variations. Journal of the American College of Cardiology. 2014 Dec 9; 64(22):2434-5.
  4. Hira RS, Kennedy K, Jneid H, Alam M, Basra SS, Petersen LA, Ballantyne CM, Nambi V, Chan PS, Virani SS. Frequency and practice-level variation in inappropriate and nonrecommended prasugrel prescribing: insights from the NCDR PINNACLE registry. [Letter to the Editor]. Journal of the American College of Cardiology. 2014 Jul 1; 63(25 Pt A):2876-7.
  5. Virani S. Dyslipidemia article of the month. “Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes). cardiosource.com. 2014 Apr 12.
  6. Rogers PA, Daye J, Huang H, Blaustein A, Virani S, Alam M, Kumar A, Paniagua D, Kar B, Bozkurt B, Ballantyne CM, Deswal A, Jneid H. Revascularization improves mortality in elderly patients with acute myocardial infarction complicated by cardiogenic shock. [Letter to the Editor]. International Journal of Cardiology. 2014 Mar 1; 172(1):239-41.
  7. Virani SS, Ballantyne CM, Petersen LA. Decrease the incentives to order lipid panels--reply. JAMA internal medicine. 2014 Mar 1; 174(3):473-4.
  8. Bandeali SJ, Daye J, Virani SS. Novel therapies for treating familial hypercholesterolemia. Current Atherosclerosis Reports. 2014 Jan 1; 16(1):382.
  9. Basra SS, Khalid U, Hira R, Bandeali SJ, Virani SS, Nambi V, Aguilar D, Jneid H, Bozkurt B, Deswal A. Impact Of Comorbidities On Heart Failure Hospitalizations and All Cause Hospitalizations In Ambulatory Patients With Heart Failure With Preserved Ejection Fraction. [Abstract]. Journal of the American College of Cardiology. 2013 Mar 12; 61(10_S):E1537.
  10. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 3; 125(1):188-97.
Book Chapters

  1. Pokharel Y, Virani SS. Hyperlipidemia. In: Levine GN, editor. Color Atlas of Clinical Cardiology. Philadelphia, PA: Jaypee Medical Publishers; 2015. Chapter 55. 951-960 p.
  2. Pokharel Y, Negi S, Virani SS. Cholesterol: Concentration, Ratio, and Particle Number. In: Clinical Lipidology: A companion to Braunwald’s Heart Disease. 2 ed. Philadelphia, PA: Elsevier; 2015. Chapter 8. 91-99 p.
Center Products

  1. Virani S. Corneal arcus and xanthelasma: Clinical Images for Practicing Physicians. This is a compilation of physical examination findings in patients with Familial Hypercholesterolemia. 2015 Apr 29.
  2. Virani S. Frequency and Practice-Level Variation in Inappropriate Aspirin Use for the Primary Prevention of Cardiovascular Disease Insights From the National Cardiovascular Disease Registry’s Practice Innovation and Clinical Excellence Registry. 2015 Feb 18.
  3. Virani S. Non-high-density Lipoprotein Cholesterol Goal Attainment: Opportunities and Challenges. 2011 Jul 25.
Conference Presentations

  1. Pokharel Y, Gosch K, Grodzinsky A, Nambi V, Chan P, Kosiborod M, Spertus J, Ballantyne C, Petersen LA, Virani S. Frequency and Practice Level Variation in Statin Use Among Patients with Diabetes: Insights From the NCDR® PINNACLE Registry. Poster session presented at: American Heart Association Annual Scientific Forum; 2015 Oct 11; Orlando, FL.
  2. Virani S. Very High Triglycerides: Epidemiology, Triglyceride Metabolism and Associated Disease Risks. Paper presented at: American College of Cardiology: Very High Triglyceride Positioning Work Group Meeting; 2015 Aug 24; Washington, DC.
  3. Petersen LA, Woodard LD, Urech TH, Pietz K, Virani SS. Is Lack of Treatment Intensification Responsible for Racial Disparities in Uncontrolled Hypertension? Paper presented at: AcademyHealth Annual Research Meeting; 2015 Jun 14; Minneapolis, MN.
  4. Pokharel Y, Akeroyd JM, Ramsey D, Hira RS, Nambi V, Shah T, Woodard LD, Winchester D, Ballantyne CM, Petersen LA, Virani SS. Statin Use and its Facility-Level Variation in Diabetes Patients: Insight from Veterans Affairs National Database. Poster session presented at: American Diabetes Association Annual Scientific Session; 2015 Jun 6; Boston, MA.
  5. Virani SS, Akeroyd JM, Ramsey D, Rajan SS, Ballantyne CM, Petersen LA. Provider Type and the Quality of Outpatient Diabetes Care: Implication for Care Delivery Under the Affordable Care Act. Paper presented at: American Diabetes Association Annual Scientific Session; 2015 Jun 5; Boston, MA.
  6. Kayani WT, Idrees N, Bandeali S, Pham D, Khan A, Wong D, Hamzeh IR, Virani SS, Lakkis NM, Alam M. The Effect of Early Surgery on Outcomes in Infective Endocarditis- A Meta-analysis of 25,732 Patients. Poster session presented at: American Heart Association Quality of Care and Outcomes Research Council Annual Scientific Session; 2015 May 1; Baltimore, MD.
  7. Hira RS, Pokharel Y, Cowart J, Akeroyd J, Ramsey D, Jneid H, Deswal A, Denktas A, Ballantyne CM, Petersen LA, Virani SS. Compliance with risk factor optimization and medical therapy in patients with peripheral vascular disease (peripheral artery and ischemic cerebrovascular disease) compared to ischemic heart disease. Paper presented at: American Heart Association Quality of Care and Outcomes Research Council Annual Scientific Session; 2015 Apr 29; Baltimore, MD.
  8. Virani S, Akeroyd JM, Ramsey D, Chan W, Rajan S, Ballantyne CM, Petersen LA. Comparative Effectiveness of Outpatient Cardiovascular Disease Care Delivery Between Physician and Non-Physician Primary Care Providers: Implications for Care Under the Affordable Care Act. Paper presented at: American Heart Association Quality of Care and Outcomes Research Council Annual Scientific Session; 2015 Apr 29; Baltimore, MD.
  9. Porkharel Y, Sun W, Nambi V, Virani SS, Solomon S, Chan W, Hoogeveen R, Chang P, Ndumele C, Selvin E, Bozkurt B, Ballantyne C, Deswal A. Pre-Morbid Body Mass Index, High Sensitivity Troponin-T and Mortality After Incident Heart Failure Hospitalization: The Atherosclerosis Risk in Communities Study (ARIC) Study. Poster session presented at: American College of Cardiology Annual Scientific Session; 2015 Mar 16; San Diego, CA.
  10. Bandeali SJ, Soomro A, Virani SS, Bandeali S, Hira R, Bassett S, Cota F, Hamzeh I, Jneid H, Nayak A, Ballantyne CM, Lakkis N, Alam M. Impact of Short versus Long Duration Dual Antiplatelet Therapy on Clinical Outcomes: A Comprehensive Meta-Analysis of All Randomized Clinical Trials. Poster session presented at: American College of Cardiology Annual Scientific Session; 2015 Mar 15; San Diego, CA.
  11. Kalra A, Pokharel Y, Hira RS, Risch S, Vicera V, Li Q, Kalra R, Kerkar PG, Kumar G, Maddox TM, Oetgen WJ, Glusenkamp N, Turakhia MP, Virani SS. Cardiovascular Disease Performance Measures in the Outpatient Setting in India: Insights from the American College of Cardiology's PINNACLE India Quality Improvement Program (PIQIP). Poster session presented at: American Association of Cardiologists of Indian Origin Annual Scientific Session; 2015 Mar 15; San Diego, CA.
  12. Virani S. Lipid Guidelines: Let’s Find Some Common Ground. Paper presented at: American College of Cardiology Annual Scientific Session; 2015 Mar 15; San Diego, CA.
  13. Virani SS. Lipid Management Today: Unanswered Questions and Unquestioned Answers. Paper presented at: American College of Cardiology Annual Scientific Session; 2015 Mar 15; San Diego, CA.
  14. Bandeali SJ, Jones P, Virani SS, Hira R, Chan P, Wilson J, Kleiman N, Lakkis N, Alam M. Factors Associated with Use of Newer Antiplatelet Agents in Patients Undergoing Drug Eluting Stent Placement: Analysis from The Pinnacle® Registry. Poster session presented at: American College of Cardiology Annual Scientific Session; 2015 Mar 14; San Diego, CA.
  15. Pham D, Hoang V, Addison D, Ahmed A, Hira R, Hamzeh I, Virani SS, Lakkis N, Alam M. Radial versus Femoral Access for Percutaneous Coronary Intervention in Non-ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of 38,587 Patients. Poster session presented at: American College of Cardiology Annual Scientific Session; 2015 Mar 14; San Diego, CA.
  16. Hira RS, Bhatt D, Fonarow G, Heidenreich P, Ju C, Virani SS, Hernandez A, Schwamm L, Eapen Z, Albert M, Peterson E, Jneid H. Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention in the Get With The Guidelines Coronary Artery Disease (GWTG-CAD) Registry. Poster session presented at: American College of Cardiology Annual Scientific Session; 2015 Mar 13; San Diego, CA.
  17. Merchant AT, Georgantopoulos P, Morales D, Howe C, Tang Y, Virani SS, Haddock KS. Effect of Periodontal Treatment and Maintenance on Glycated Hemoglobin. Paper presented at: International Association for Dental Research General Annual Session; 2015 Mar 11; Boston, MA.
  18. Stevens J, Erber-Oakkar E, Cui Z, Cai J, Wormser D, Virani SS. 2013 AHA/ACC/TOS and 1998 NHLBI Clinical Guidelines for the Management of Overweight and Obesity Predict Higher Cardiovascular Disease Risk in Adults Recommended versus Not Recommended for Weight Loss Treatment: the Atherosclerosis Risk in Communities Study. Poster session presented at: American Heart Association Epidemiology and Prevention, Nutrition, Physical Activity, and Metabolism Scientific Sessions; 2015 Mar 5; Orlando, FL.
  19. Virani SS. Advanced Lipoprotein Testing. Does it Help or Confuse? Paper presented at: Aga Khan University Hospital Department of Medicine Quarterly Grand Rounds; 2014 Dec 22; Karachi, Pakistan.
  20. Pokharel Y, Hira RS, Shore S, Kerkar PG, Kumar G, Risch S, Vicera V, Oetgen WJ, Turakhia M, Glusenkamp N, Virani SS. Guideline Recommended Medication Use among Systolic Heart Failure Patients in India: Insights from the American College of Cardiology Practice Innovation and Clinical Excellence (PINNACLE)® India Registry. Paper presented at: Cardiological Society of India Annual Conference; 2014 Dec 5; Hyderabad, India.
  21. Hoang V, Addison D, Alam M, Virani SS, Birnbaum Y. The Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Coronary Artery Disease and No Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials. Poster session presented at: American Heart Association Annual Scientific Sessions; 2014 Nov 19; Chicago, IL.
  22. Virani SS, Maddox TM, Chan PS, Tang F, Akeroyd JM, Risch S, Deswal A, Bozkurt B, Ballantyne CM, Petersen LA. Provider Type and Quality of Outpatient Cardiovascular Disease Care, Implications for the Affordable Care Act: Insights from the NCDR®PINNACLE Registry. Paper presented at: American Heart Association Annual Scientific Forum; 2014 Nov 19; Chicago, IL.
  23. Yousif A, Addison D, Lakkis N, Rosengart T, Burnbaum Y, Virani SS, Hamzeh I, Alam M. Is Coronary Artery Bypass Grafting (CABG) with Cardiopulmonary Bypass Support (On-pump) Superior to CABG Without Bypass Support (Off-pump) in the High-Risk? A Meta-Analysis of Randomized Controlled Trials (RCTs). Poster session presented at: American Heart Association Annual Scientific Sessions; 2014 Nov 19; Chicago, IL.
  24. Alam M, Yaqoob M, Hamzeh IR, Virani SS, Hira RS, Bandeali SS, Macedo F, Hameed MA, Lakkis NM. Hemodynamic Effects of Ultrasound-Guided Catheter Directed Thrombolysis (UCDT) in Patients With Massive or Sub-Massive Pulmonary Embolism. Poster session presented at: American Heart Association Annual Scientific Sessions; 2014 Nov 18; Chicago, IL.
  25. Basra S, Bandeali SJ, Nambi V, Nasir K, Martin S, Vogel RA, Roberts AJ, Ballantyne CM, Virani SS. Do Retired National Football League Linemen Have a Higher Prevalence and Severity of Subclinical Atherosclerosis Compared With Non-Linemen? Paper presented at: American Heart Association Annual Scientific Forum; 2014 Nov 18; Chicago, IL.
  26. Kumar V, Virani SS, Bassett S, Alam M, Hira R, Caruso A, Paniagua D, Denktas A, Hamzeh I, Levine G, Ballantyne CM, Deswal A, Bozkurt B, Jneid H. Persistent Thrombocytopenia after Myocardial Infarction is Associated with Increased Short- and Long-Term Mortality. Poster session presented at: American Heart Association Annual Scientific Sessions; 2014 Nov 17; Chicago, IL.
  27. Pokharel Y, Sun W, Villarael D, Selvin E, Virani SS, Ndumele CE, Hoogeveen RC, Coresh J, Boerwinkle E, Butler K, Solomon S, Pankow JS, Bozkurt B, Ballantyne CM, Nambi V. High Sensitivity Troponin T is Associated With Increased Heart Failure Risk in Metabolic Syndrome in the Atherosclerosis Risk in Communities (ARIC) Study. Poster session presented at: American Heart Association Annual Scientific Sessions; 2014 Nov 17; Chicago, IL.
  28. Kamaran H, Nambi V, Negi S, Yang EY, Chen C, Virani SS, Kougias P, Lumsden AB, Moorrisett JD, Ballantyne CM, Brunner G. MRI Venous Volume Measurements are Associated With Ankle Brachial Index in Peripheral Artery Disease Patients: Results From the Effect of Lipid Modification on Peripheral Arterial Disease After Endovascular Intervention Trial (ELIMIT). Poster session presented at: American Heart Association Annual Scientific Sessions; 2014 Nov 16; Chicago, IL.
  29. Ahmed A, Pham D, Virani SS, Hamzeh IR, Jneid H, Lakkis N, Alam M. Does Gender Still Influence Mortality Post Percutaneous Coronary Intervention (PCI)? A Meta-Analysis of the Impact of Gender on PCI Outcomes. Presented at: American Heart Association Annual Scientific Sessions; 2014 Nov 15; Chicago, IL.
  30. Hira RS, Kennedy K, Nambi V, Jneid H, Alam M, Basra SS, Ho M, Deswal A, Ballantyne CM, Petersen LA, Virani SS. Frequency and Practice-Level Variation In Inappropriate Aspirin Use for Primary Prevention of Cardiovascular Disease: Insights from the NCDR®PINNACLE Registry. Poster session presented at: American Heart Association Annual Scientific Sessions; 2014 Nov 15; Chicago, IL.
  31. Woodard LD, Virani S, Adepoju OE, Ramsey D, Amspoker A, Petersen LA. Lack of Racial Disparities in Glycemic and Lipid Control among Female Diabetic Patients in the Veterans Health Administration. Poster session presented at: AcademyHealth Annual Research Meeting; 2014 Jun 8; San Diego, CA.
  32. Woodard LD, Virani S, Petersen LA, Amspoker A, Urech T, Ramsey D, Adepoju OE, Mehta P, Murawsky J, Naik AD. Disparities in Glycemic and Lipid Control among Diabetic Patients in the Veterans Administration: Implications in the Era of the Affordable Care Act. Poster session presented at: AcademyHealth Annual Research Meeting; 2014 Jun 7; San Diego, CA.
  33. Hira RS, Kennedy K, Nambi V, Jneid H, Alam M, Basra SS, Ho M, Deswal A, Ballentyne CM, Petersen LA, Virani S. Frequency and Practice-Level Variation In Inappropriate Aspirin Use for Primary Prevention of Cardiovascular Disease: Insights from the NCDR®PINNACLE Registry. Paper presented at: American Heart Association Quality of Care and Outcomes Research Council Annual Scientific Session; 2014 Jun 3; Baltimore, MD.
  34. Virani S, Woodard LD, Akeroyd JM, Wang D, Chitwood SS, Landrum CR, Urech TH, Pietz K, Chen GJ, Hertz B, Murawsky J, Ballantyne CM, Petersen LA. Frequency and Correlates of Repeat Lipid Testing in Patients with Coronary Heart Disease. Poster session presented at: Baylor College of Medicine Quality and Safety Annual Conference; 2014 May 15; Houston, TX.
  35. Pokharel Y, Namib V, Martin SS, Hoogeveen RC, Nasir K, Wong ND, Jones PH, Boone J, Roberts AJ, Ballantyne CM, Virani S. Association between Low Density Lipoprotein Cholesterol or Low Density Lipoprotein Particle Concentration and Metabolic Syndrome and High Sensitivity C-reactive Protein in Retired National Football League Players. Poster session presented at: National Lipid Association Annual Scientific Sessions; 2014 May 4; Orlando, FL.
  36. Pokharel Y, Nambi V, Martin SS, Hoogeveen RC, Nasir K, Wong ND, Jones PH, Boone J, Roberts AJ, Ballantyne CM, Virani S. Lipoprotein Associated Phospholipase A2 Mass is Not Associated with Subclinical Coronary and Carotid Atherosclerosis in the Retired National Football League Players. Poster session presented at: National Lipid Association Annual Scientific Sessions; 2014 May 3; Orlando, FL.
  37. Pokharel Y, Sun W, Virani S, Nambi V, Jones PH, Ballantyne CM, Hoogeveen RC. Association of Combination of Small Dense Low-Density Lipoprotein Cholesterol and Lipoprotein-Associated Phospholipase A2 with Cardiovascular Disease and Carotid Plaque Characteristics in the Atherosclerosis Risk in Communities Study. Poster session presented at: National Lipid Association Annual Scientific Sessions; 2014 May 2; Orlando, FL.
  38. Virani S. Effectiveness, Efficiency, Safety, and Equity in the Delivery of Cardiovascular Care: Lessons Learned from the Department of Veterans Affairs and National Cardiovascular Disease Registries. Paper presented at: VA HSR&D Informatics, Decision-Enhancement and Analytic Sciences Center Annual Meeting; 2014 Apr 24; Salt Lake City, UT.
  39. Woodard LD, Virani S, Petersen LA, Amspoker A, Urech T, Ramsey D, Adepoju OE, Muraswky J, Mehta P, Naik AD. Disparities in Glycemic and Lipid Control among Diabetic Patients in the Veterans Administration: Implications in the Era of the Affordable Care Act. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2014 Apr 24; San Diego, CA.
  40. Jiwani R, Virani S, Prasad A, Cleveland L, Berndt A, Gill S. Illness Perceptions, Coping Behaviors, and Appraisal of South Asian Immigrants with Coronary Artery Disease: A Mixed Methods Study. Poster session presented at: Preventive Cardiovascular Nurses Association Annual Symposium; 2014 Apr 11; Atlanta, GA.
  41. Virani S. The interface of Epidemiology and Health Services Research in Cardiovascular Disease. Presented at: University of Texas Southwestern Medical Center Visiting Scholar Quarterly Seminar; 2014 Apr 9; Dallas, TX.
  42. Miller ME, Martin S, Toth PP, Blaha M, Nasir K, Virani S, Blumenthal RS, Post W, Jones S. Comparison of Friedewald and Biologic LDL-C in Familial Hypercholesterolemia Screening: The Very Large Database of Lipids Study-17 (VLDL-17). Poster session presented at: American College of Cardiology Annual Scientific Session; 2014 Mar 30; Washington, DC.
  43. Virani S. Do these Multiple Lipid and Biomarker Panels Help or Confuse? Paper presented at: American College of Cardiology Annual Scientific Session; 2014 Mar 30; Washington, DC.
  44. Virani S, Woodard LD, Ramsey DJ, Ballantyne CM, Petersen LA. Is High-Dose Statin Therapy Associated with Lower Statin Adherence Compared with Low-Dose Statin Therapy? An Analysis from a National Cohort. Paper presented at: American College of Cardiology Annual Scientific Session; 2014 Mar 30; Washington, DC.
  45. Pokharel Y, Sun W, Taffet G, Virani S, De Lemos J, Ndumele CE, Mosley T, Hoogeveen RC, Coresh J, Solomon S, Heiss G, Boerwinkle E, Bozkurt B, Ballantyne CM, Nambi V. Troponin T Identifies Individuals at Higher Risk for Heart Failure among All Blood Pressure Categories in the Atherosclerosis Risk In Communities (ARIC) Study. Poster session presented at: American College of Cardiology Annual Scientific Session; 2014 Mar 29; Washington, DC.
  46. Federspiel JJ, Sueta CA, Kucharska-Newton AM, Virani S, Rodgers JE, Chang PP, Stearns SC. Medicare Part D Medication Use in a Community Cohort With Hypertension: The Atherosclerosis Risk in Communities (ARIC) Study. Poster session presented at: American Heart Association Annual Scientific Forum; 2013 Nov 20; Dallas, TX.
  47. Khalid U, Ather S, Bavishi C, Chan W, Loehr LR, Wruck LM, Rosamand WD, Chang PP, Coresh J, Virani S, Nambi V, Bozkurt B, Ballantyne CM, Deswal A. Obesity Paradox in Heart Failure: Not All Cardiac Cachexia. Poster session presented at: American Heart Association Annual Scientific Forum; 2013 Nov 20; Dallas, TX.
  48. Khalid U, Wruck LM, Quibrera PM, Bozkurt B, Nambi V, Virani S, Basra S, Agarwal S, Chang PP, Loehr LL, Rosamind WD, Ballantyne CM, Deswal A. BNP as a Prognostic Marker in Obese Patients With Acute Heart Failure With Preserved vs. Reduced Ejection Fraction. Paper presented at: American Heart Association Annual Scientific Forum; 2013 Nov 20; Dallas, TX.
  49. Virani S, Sun W, Dodge R, Nambi V, Coresh J, Mosley TH, Sharrett AR, Boerwinkle E, Ballantyne CM, Wasserman BA. Carotid Artery Plaque Burden and Characteristics and Subsequent Risk of Incident Cardiovascular Events: The ARIC Carotid MRI Study. Paper presented at: American Heart Association Annual Scientific Forum; 2013 Nov 20; Dallas, TX.
  50. Dadu RT, Dodge R, Virani S, Nambi V, Hoogeveen RC, Coresh J, Mosley TH, Pankow JS, Boerwinkle E, Ballantyne CM. SDF 1 Alpha and Carotid plaque Characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. Poster session presented at: American Heart Association Annual Scientific Forum; 2013 Nov 19; Dallas, TX.
  51. Alam M, Hira R, Kar B, Jneid H, Virani S, Goswami R, Bandeali SJ, Rosengart T, Coselli J, Kleiman N, Ballantyne CM, Lakkis NM. Comparison of Clinical Outcomes After Trans-catheter Aortic Valve Implantation in Men and Women for Severe Aortic Stenosis. Poster session presented at: American Heart Association Annual Scientific Forum; 2013 Nov 18; Dallas, TX.
  52. Hira RS, Huang HD, Hamzeh I, Alam M, Paniagua D, Kar B, Bakaeen F, Rabeneck L, Rosengart T, Virani S, Ballantyne CM, Bozkurt B, Deswal A, Jneid HM. Safety of Deferral of Revascularization Following Invasive Assessment of Intermediate Left Main Coronary Artery Disease. A Meta-Analysis of Comparative Clinical Studies. Poster session presented at: American Heart Association Annual Scientific Forum; 2013 Nov 18; Dallas, TX.
  53. Manalac R, Martin SS, Blaha MJ, Toth PP, Kulkarni KR, Nasir K, Virani S, Blumenthal RS, Jones SR. Correlates and Cut-points of the Triglyceride/HDL Cholesterol Ratio: The Very Large Database of Lipids 4 (VLDL-4). Poster session presented at: American Heart Association Annual Scientific Forum; 2013 Nov 18; Dallas, TX.
  54. Virani S, Woodard LD, Ramsey DJ, Urech TH, Shah T, Bozkurt B, Ballantyne CM, Petersen LA. Are women with cardiovascular disease less likely to receive evidence based statin therapy compared with men? An analysis from a national cohort. Poster session presented at: American Heart Association Annual Scientific Sessions; 2013 Nov 18; Dallas, TX.
  55. Nambi V, Virani S, Couper D, Hoogeveen RC, Astor B, Mosley T, Boerwinkle E, Coresh J, Sharrett R, Folsom AR, Ballantyne CM. Biomarkers' Association With Incident Cardiovascular Events is Not Modified by Presence/Severity of Sub Clinical Carotid Atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. Paper presented at: American Heart Association Annual Scientific Forum; 2013 Nov 17; Dallas, TX.
  56. Ogunwale A, Morrison AC, Dodge R, Virani S, Taylor A, Gottesman R, Yang E, Wei P, Boerwinkle E, Heiss G, Ballantyne CM, Nambi C. Multiple Single Day Blood Pressure Measurements and Their Impact on Coronary Heart Disease, Stroke, and Heart Failure Risk Prediction: The Atherosclerosis Risk In Communities (ARIC) Study. Poster session presented at: American Heart Association Annual Scientific Forum; 2013 Nov 17; Dallas, TX.
  57. Basra S, Khalid S, Virani S, Nambi V, Aguilar D, Jneid H, Bozkurt B, Deswal A. The “Obesity Paradox” in Ambulatory Patients With Heart Failure With Preserved Ejection Fraction. Paper presented at: American Heart Association Annual Scientific Forum; 2013 Nov 16; Dallas, TX.
  58. Negi SI, Lopez F, Alonso A, Virani S, Boerwinkle E, Baggett C, Guild C, Matsushita K, Hoogeveen RC, Ballantyne CM, Nambi V. Association of Electrocardiographic Parameters With Cardiac Troponin-T Measured With a High Sensitivity Assay in the Atherosclerosis Risk in Communities Study. Poster session presented at: American Heart Association Annual Scientific Forum; 2013 Nov 16; Dallas, TX.
  59. Alam M, Bandeali S, Basra S, Virani S, Jneid H, Paniagua D, Kar B, Bakaeen FG, Coselli JS, Rosengart TK, Kleiman N, Ballantyne CM, Lakkis NM. All-Cause Mortality after Surgical or Trans-Catheter Aortic Valve Replacement in Patients with Low-Flow Low-Gradient Aortic Stenosis. Paper presented at: Transcatheter Cardiovascular Therapeutics Annual Scientific Conference; 2013 Nov 1; San Francisco, CA.
  60. Abbass IM, Virani SS, Parikh R, Taychakhoonavudh S, Ganduglia C, Franzini L. Patterns of Care, Costs And Outcomes Of Chest Pain Patients Within Two Years of Initial Visits To The ER. Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; 2013 May 18; New Orleans, LA.
  61. Bandeali SJ, Gosch K, Negi SI, Alam M, Kayani WT, Wilson JM, Chan PS, Maddox TM, Virani SS. Differences in compliance with coronary artery disease performance metrics and statin use in patients with recent coronary artery bypass grafting (CABG) versus those with recent percutaneous coronary intervention (PCI): An Analysis from the Patient Innovation and Clinical Excellence (PINNACLE®) registry. Poster session presented at: American Heart Association Quality of Care and Outcomes Research Council Annual Scientific Session; 2013 May 15; Baltimore, MD.
  62. Brunner G, Yang EY, Kumar A, Wensheng S, Virani S, Negi S, Murray T, Lin PH, Hoogeveen RC, Chen C, Kougias P, Taylor A, Lumsden AB, Nambi V, Ballantyne CM, Morrisett JD. The Effect of Lipid Modification on Peripheral Arterial Disease after Endovascular Intervention Trial (ELIMIT). Paper presented at: American Heart Association Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference; 2013 May 1; Lake Buena Vista, FL.
  63. Alam A, Siddiqui KH, Bandeali S, Virani S, Jneid H, Goswami R, Ballantyne C, Kleiman N, Lakkis N. Chronic Total Occlusions: Impact of Successful and Failed Recanalization on Short and Long-Term Survival. Poster session presented at: American College of Cardiology Annual Scientific Session; 2013 Mar 9; San Francisco, CA.
  64. Alam M, Bandeali S, Kayani W, Shahzad SA, Jneid H, Birnbaum Y, Kleiman N, Coselli J, Ballantyne C, Lakkis N, Virani S. Impact of Female Gender on Mortality after Isolated Coronary Artery Bypass Grafting. Poster session presented at: American College of Cardiology Annual Scientific Session; 2013 Mar 9; San Francisco, CA.
  65. Bandeali SJ, Choudhary MM, Virani S, Jneid H, Sewani SA, Wagas A, Basra S, Tsai P, Kleiman N, Coselli J, Lakkis N, Alam M. PCI or Coronary Artery Bypass Graft: Implications in End-Stage Renal Disease Patients. Poster session presented at: American College of Cardiology Annual Scientific Session; 2013 Mar 9; San Francisco, CA.
  66. Basra SS, Khalid MU, Hira R, Bandeali S, Virani S, Nambi V, Aguilar D, Jneid H, Bozkurt B, Deswal A. Impact of Comorbidities on Heart Failure Hospitalizations and All Cause Hospitalizations in Ambulatory Patients with Heart Failure with Preserved Ejection Fraction. Poster session presented at: American College of Cardiology Annual Scientific Session; 2013 Mar 9; San Francisco, CA.
  67. Virani S. Lipid Treatment Updates for 2013. Paper presented at: American College of Cardiology Annual Scientific Session; 2013 Mar 9; San Francisco, CA.
  68. Virani S, Lee VV, Brautbar A, Grove-Goana M, Nambi V, Alam M, Elayda A, Wilson J, Willerson J, Boerwinkle E, Ballantyne C. Novel Investigations in Lipidology. Paper presented at: American College of Cardiology Annual Scientific Session; 2013 Mar 9; San Francisco, CA.
  69. Virani S. Advanced Lipoprotein Testing and Novel Drugs in Dyslipidemia Management. Paper presented at: Advances in Medicine and Subspecialties Conference; 2013 Feb 13; Abu Dhabi, United Arab Emirates.
  70. Virani S. National Program to Reduce Cardiovascular Risk (NPRCR) Infrastructure and Scope. Presented at: National Heart, Lung, and Blood Institute / National Program to Reduce Cardiovascular Risk Coordinating Committee Meeting; 2012 Dec 7; Bethesda, MD.
  71. Martin SS, Blaha MJ, Blankstein R, Lloyd-Jones D, Agatston A, Rivera JJ, Virani S, Ouyang P, Jones SR, Blumenthal RS, Budoff MJ, Nasir K. Coronary artery calcium stratifies risk across varying levels of dyslipidemia: The multi-ethnic study of atherosclerosis (MESA). Poster session presented at: American Heart Association Annual Scientific Sessions; 2012 Nov 3; Los Angeles, CA.
  72. Nambi V, Chambless L, De Lemos JA, Agarwal S, Virani S, Aguilar D, Srinivas P, Deswal A, Mosley T, Boerwinkle E, Hoogeveen RC, Coresh J, Folsom AR, Heiss G, Ballantyne CM. High sensitivity troponin T and NT-proBNP in heart failure risk prediction: An analysis from the atherosclerosis risk in communities (ARIC) study. Paper presented at: American Heart Association Annual Scientific Sessions; 2012 Nov 3; Los Angeles, CA.
  73. Virani SS, Woodard LD, Wang D, Landrum CR, Chitwood SS, Urech TH, Pietz K, Hertz B, Ballantyne CM, Petersen LA. Correlates of multiple lipid panels in patients with coronary heart disease who have achieved LDL cholesterol treatment goals. Poster session presented at: VA HSR&D National Meeting; 2012 Jul 18; Washington, DC.
  74. Urech T, Simpson K, Woodard LD, Virani S, Kuebeler M, Dudley RA, Lutschg MZ, Petersen LA. Measuring guideline-recommended care of hypertension: Agreement between chart review and automated processing of electronic medical record data. Poster session presented at: AcademyHealth Annual Research Meeting; 2012 Jun 24; Orlando, FL.
  75. Bandeali SJ, Kayani WT, Lee VV, Elayda MA, Nambi V, Jneid H, Alam M, Wilson JM, Birnhaum Y, Ballantyne CM, Virani SS. The outcomes of pre-procedural angiotensin converting enzyme inhibitor therapy in patients undergoing percutaneous coronary intervention. Poster session presented at: American Heart Association Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Annual Scientific Sessions; 2012 May 9; Atlanta, GA.
  76. Bandeali SJ, Kayani WT, Lee VV, Pan W, Elayda MA, Nambi V, Jneid H, Alam M, Wilson JM, Birnhaum Y, Ballantyne CM, Virani SS. Preoperative angiotensin converting enzyme inhibitor use and outcomes in patients undergoing isolated coronary artery bypass grafting. Poster session presented at: American Heart Association Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Annual Scientific Sessions; 2012 May 9; Atlanta, GA.
  77. Kayani WT, Bandeali SJ, Lee VV, Elayda MA, Huang HD, Nambi V, Alam M, Wilson JM, Birnbaum Y, Ballantyne CM, Virani SS. The effect of pre-operative statins on incidence of infections after coronary artery bypass grafting. Poster session presented at: American Heart Association Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Annual Scientific Sessions; 2012 May 9; Atlanta, GA.
  78. Petersen LA, Urech TH, Simpson K, Woodard LD, Virani S, Kuebeler MK, Lutschg M, Dudley RA. Impact of using administrative vs, chart-abstracted data on calculations of financial incentives for health care providers in a pay-for-performance program. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2012 May 9; Orlando, FL.
  79. Dadu RT, Dodge R, Nambi V, Virani S, Hoogeveen RC, Pankow JS, Coresh J, Guild C, Tang WH, Boerwinkle E, Hazen SL, Ballantyne CM. Ceruloplasmin and cardiovascular disease in the atherosclerosis risk in communities (ARIC) study. Poster session presented at: American Heart Association Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference; 2012 Apr 18; Chicago, IL.
  80. Gaubatz JW, Sun W, Jiang J, Buchanan A, Couper D, Virani S, Boerwinkle E, Ballantyne CM, Hoogeveen RC. Small dense LDL (sd-LDL) is associated with risk for coronary heart disease: The atherosclerosis risk in communities (ARIC) study. Poster session presented at: American Heart Association Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference; 2012 Apr 18; Chicago, IL.
  81. Alam M, Bandeali S, Kayani W, Huang H, Virani S, Ramanathan K, Jneid H. The impact of colchicines on the incidence and recurrence of pericardial inflammation: A comprehensive meta-analysis of all randomized clinical trials. Paper presented at: American College of Cardiology Annual Scientific Session; 2012 Mar 24; Chicago, IL.
  82. Virani S. Update in lipids. Paper presented at: American College of Cardiology Annual Scientific Session; 2012 Mar 24; Chicago, IL.
  83. Yang EY, Brunner G, Dokainish H, Virani S, Lakkis N, Misra A, McCulloch M, Hartley CJ, Morrisett JD, Ballantyne CM, Nagueh S, Nambi V. Segmental analysis of circumferential systolic carotid arterial strain in diabetics and hypertensives using 2D speckle tracking. Poster session presented at: American College of Cardiology Annual Scientific Session; 2012 Mar 24; Chicago, IL.
  84. Polonsky T, Chambless L, Mao L, Greenland P, Virani S, Astor B, Fox E, Hoogeveen R, Mosely T, Ni H, Ballantyne CM, Nambi V. High sensitivity C-reactive protein and family history in the prediction of risk for coronary heart disease: The atherosclerosis risk in communities (ARIC) study. Poster session presented at: American Heart Association Epidemiology and Prevention, Nutrition, Physical Activity, and Metabolism Scientific Sessions; 2012 Mar 14; San Diego, CA.
  85. Virani S. Hot off the press. Poster session presented at: American Heart Association Epidemiology and Prevention, Nutrition, Physical Activity, and Metabolism Scientific Sessions; 2012 Mar 14; San Diego, CA.
  86. Virani S, Brautbar A, Davis BC, Nambi V, Hoogeveen RC, Sharrett AR, Coresh J, Mosley TH, Morrisett JD, Catellier DJ, Folsom AR, Boerwinkle E, Ballantyne CM. Associations between lipoprotein (a) levels and cardiovascular outcomes in black and white subjects: The Atherosclerosis Risk in Communities (ARIC) Study. Poster session presented at: American Heart Association Epidemiology and Prevention, Nutrition, Physical Activity, and Metabolism Scientific Sessions; 2012 Mar 14; San Diego, CA.
  87. Alam A, Bandeali SJ, Shahzad SA, Virani SS, Jneid HM, Ramanathan KB, Kleiman NS, Lakkis NM. Clinical outcomes of saphenous vein graft interventions using drug eluting stents compared with bare metal stents: A comprehensive meta-analysis of all randomized clinical trials. Poster session presented at: American Heart Association Annual Scientific Sessions; 2011 Nov 12; Orlando, FL.
  88. Kumar A, Yang EY, Brunner G, Murrary TO, Garami Z, Volpi J, Virani S, Washbrun MJ, Zang W, Lawrie GM, Kabir R, Ballantyne CM, Morrisett JD, Nambi V. Plaque volume of carotid endarterectomy (CEA) specimens measured using a novel 3-dimensional ultrasound (3DUS) technology. Poster session presented at: American Heart Association Annual Scientific Sessions; 2011 Nov 12; Orlando, FL.
  89. Virani S. Does reporting non-high-density-lipoprotein cholesterol (non-HDL-C) levels on standard lipid panel improve non-HDL-C goal attainment. Paper presented at: American Heart Association Annual Scientific Sessions; 2011 Nov 12; Orlando, FL.
  90. Virani S, Pompeii L, Lincoln AE, Dunn RE, Tucker AM, Nambi V, Nasir K, Vogel RA, Wong ND, Roberts AJ, Ballantyne CM. Measures of adiposity and presence of subclinical atherosclerosis in retired national football league players. Poster session presented at: American Heart Association Annual Scientific Sessions; 2011 Nov 12; Orlando, FL.
  91. Virani SS, Woodard LD, Landrum CR, Pietz K, Wang D, Ballantyne CM, Petersen LA. Institutional, provider, and patient correlates of LDL and non-HDL cholesterol goal attainment according to the adult treatment panel III guidelines. Poster session presented at: Northwestern University / Northwestern Memorial Hospital's Northwestern Cardiovascular Young Investigators' Forum; 2011 Sep 22; Chicago, IL.
  92. Virani S. Future fields of studies program: a discussion on emerging careers in health care. Paper presented at: Aga Khan Education Board Southwest Regional Meeting; 2011 Aug 26; San Antonio, TX.
  93. Woodard LD, Landrum CR, Wang D, Urech T, Virani S, Petersen LA. The impact of clinical complexity on achievement of glycemic, blood pressure, and lipid control among patients with diabetes. Paper presented at: AcademyHealth Annual Research Meeting; 2011 Jun 12; Seattle, WA.
  94. Negi SI, Polsani VR, Garg V, Gowani S, Marinescu V, Zorriasateyn K, Ahmed Z, Petersen LA, Ballantyne CM, Steinberg L, Nambi V, Jones PH, Alizadehsovari A, Virani S. Analysis of knowledge and barriers to non-high density cholesterol goal attainment among physicians-in-training. Poster session presented at: National Lipid Association Annual Scientific Sessions; 2011 May 19; New York, NY.
  95. Virani S, Steinberg L, Murray T, Negi S, Nambi V, Woodard LD, Bozhurt B, Petersen LA, Ballantyne CM. Barriers to non-HDL cholesterol goal attainment by providers. Poster session presented at: National Lipid Association Annual Scientific Sessions; 2011 May 19; New York, NY.
  96. Virani S, Woodard LD, Sookanan S, Landrum CR, Urech TH, Wang D, Murawsky J, Ballantyne CM, Petersen LA. Frequency and correlates of low-density lipoprotein cholesterol (LDL-C) control and treatment intensification in patients with cardiovascular disease. Poster session presented at: American Heart Association Quality of Care and Outcomes Research Council Annual Scientific Session; 2011 May 12; Washington, DC.
  97. Woodard LD, Landrum CR, Wang D, Urech T, Virani S, Petersen LA. The effect of clinical complexity on the receipt of comprehensive care for diabetes. Paper presented at: Society of General Internal Medicine Annual Meeting; 2011 May 4; Phoenix, AZ.
  98. Alam M, Lee VV, Elayda MA, Nambi V, Jneid HM, Wilson JM, Ballantyne CM, Virani SS. Impact of gender on mortality and morbidity after isolated coronary artery bypass grafting: A propensity score matched analysis of outcomes. Poster session presented at: American College of Cardiology Annual Scientific Session; 2011 Apr 2; New Orleans, LA.
  99. Nambi V, Pompeii L, Sharrett AR, Yang E, Brautbar A, Franceschini N, North K, Coresh J, Virani SS, Ballantyne CM, Boerwinkle E. Association between a single nucleotide polymorphism in chromosome 9p21 and arterial stiffness in the atherosclerosis risk in communities study. Poster session presented at: American College of Cardiology Annual Scientific Session; 2011 Apr 2; New Orleans, LA.
  100. Nambi V, Saunders J, Chambless L, de Lemos JA, Liu X, Virani SS, Boerwinkle E, Hoogeveen RC, Astor BC, Mosley TH, Folsom AR, Coresh J, Ballantyne CM. High sensitivity troponin is associated with mortality, coronary heart disease, and heart failure in individuals with prevalent cardiovascular disease in the atherosclerosis risk in communities (ARIC Study). Paper presented at: American College of Cardiology Annual Scientific Session; 2011 Apr 2; New Orleans, LA.
  101. Negi S, Brunner G, Kumar A, Yang EY, Murray T, Athamneh H, Saunders JT, Shah DJ, Bechara C, Lin PH, Chen C, Lumsden AB, Virani SS, Nambi V, Ballantyne CM. MRI venous volume measurements in peripheral arterial disease: A pilot study from the effect of lipid modification on peripheral arterail disease after endovascular intervention (ELIMIT) study. Poster session presented at: American College of Cardiology Annual Scientific Session; 2011 Apr 2; New Orleans, LA.
  102. Negi S, Nambi V, Virani SS, Kumar A, Lumsden AB, Chen C, Ballantyne CM, Dong JF. Diabetic status does not affect platelet function assays in peripheral arterial disease patients in high dose aspirin: An analysis from the effect of lipid modification on periperal arterial disease after endovascular intervention (ELIMIT) trial. Poster session presented at: American College of Cardiology Annual Scientific Session; 2011 Apr 2; New Orleans, LA.
  103. Virani SS, Brautbar A, Lee VV, Elayda MA, Sami S, Nambi V, Frazier L, Wilson JM, Willerson JT, Beorwinkle E, Ballantyne CM. Single nucleotide polymorphisms in chromosome 4q25 predict in-hospital and long term development of atrial fibrillation and survival in patients undergoing coronary artery bypass grafting. Paper presented at: American College of Cardiology Annual Scientific Session; 2011 Apr 2; New Orleans, LA.
  104. Virani SS, Lincoln AE, Dunn RE, Tucker AM, Nambi V, Nasir K, Vogel RA, Roberts AJ, Ballantyne CM. Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers, and carotid plaques in retired national football league players. Paper presented at: American College of Cardiology Annual Scientific Session; 2011 Apr 2; New Orleans, LA.
  105. Ndumele CE, Matsushita K, Astor B, Virani SS, Mora S, Williams EK, Blumenthal RS, Sharrett AR, Ballantyne CM, Coresh J. Apolipoprotein B and A1 do not add to non-HDL-C and HDL-C as risk factors for incident CHD among individuals with elevated cardiometabolic risk: The ARIC study. Poster session presented at: American Heart Association Nutrition, Physical Activity and Metabolism / Cardiovascular Disease Epidemiology and Prevention Annual Scientific Sessions; 2011 Mar 23; Atlanta, GA.
  106. Virani SS, Brautbar A, Davis BC, Nambi V, Hoogeveen RC, Sharrett AR, Coresh J, Mosley TH, Morrisett JD, Catellier DJ, Folsom AR, Boerwinkle E, Ballantyne CM. Association between lipoprotein(a) levels and cardiovascular outcomes in African Americans and Caucasians: The atherosclerosis risk in communities study. Poster session presented at: American Heart Association Nutrition, Physical Activity and Metabolism / Cardiovascular Disease Epidemiology and Prevention Annual Scientific Sessions; 2011 Mar 23; Atlanta, GA.
  107. Virani S, Woodard LD, Landrum C, Wang D, Ballantyne CM, Petersen LA. Frequency and predictors of low-density lipoprotein cholesterol (LDL-C) control and appropriate follow-up care to elevated LDL-C levels in patients with cardiovascular disease. Poster session presented at: VA HSR&D National Meeting; 2011 Feb 16; Washington, DC.
  108. Virani S, Woodard LD, Landrum CR, Pietz KC, Wang D, Ballantyne CM, Petersen LA. Institutional, provider, and patient correlates of LDL and non-HDL cholesterol goal attainment according to the adult treatment panel III guidelines. Poster session presented at: Northwestern University / Northwestern Memorial Hospital's Northwestern Cardiovascular Young Investigators' Forum; 2010 Oct 1; Chicago, IL.
  109. Virani S, Woodard LD, Petersen LA. Has LDL cholesterol (LDL-C) and non-HDL cholesterol (non-HDL-C) goal attainment improved 7 years after adult treatment panel III (ATP III) guidelines were published? Poster session presented at: American Heart Association Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Annual Scientific Sessions; 2010 May 21; Washington, DC.


DRA: Health Systems, Cardiovascular Disease
DRE: Epidemiology, Treatment - Observational
Keywords: Cardiovasc’r disease, Outcomes
MeSH Terms: none

Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.